Strides Pharma Science Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 101 to 108 & 153, SIDCO Pharmaceutical Complex, Alathur, Chengalpattu, Tamil Nadu 603110, India (IND)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3005151016 · DUNS 860477684
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-04-05
- NAIDrug Quality Assurance2019-08-09
- VAIDrug Quality Assurance2016-11-25
- VAIDrug Quality Assurance2015-03-06
- VAIDrug Quality Assurance2013-09-13
- VAIDrug Quality Assurance2011-10-17
- NAIDrug Quality Assurance2009-04-09
Drugs this plant is listed as making
7 distinct drugs across 21 products name this site in their FDA label.
- Amantadine HydrochlorideStrides Pharma Inc.
- doxycyclineStrides Pharma Science Limited
- GabapentinACI Healthcare USA, Inc.
- IbuprofenStrides Pharma Science Limited
- ModafinilHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- nystatinHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.